News

28 October 2022

Nuevocor to Present Pre-clinical Data on its Gene Therapy Candidate for LMNA Dilated Cardiomyopathy at American Heart Association Scientific Sessions 2022

18 June 2021

Nuevocor closes US$24M Series A Financing to Advance Novel Gene Therapies for Cardiomyopathies